|
Alemtuzumab
|
Visite: 148
|
|
Altretamine
|
Visite: 336
|
|
Aminoglutetimide
|
Visite: 293
|
|
L'Acido 5-Aminolevulinico
|
Visite: 246
|
|
Idrossicarbamide
|
Visite: 157
|
|
Anastrozole
|
Visite: 317
|
|
Arsenico Triossido Di
|
Visite: 282
|
|
Asparaginasi
|
Visite: 272
|
|
Bevacizumab
|
Visite: 161
|
|
Bexarotene
|
Visite: 307
|
|
Bleomicina
|
Visite: 301
|
|
Busulfan
|
Visite: 273
|
|
Capecitabina
|
Visite: 290
|
|
Carboplatino
|
Visite: 335
|
|
Carmustina
|
Visite: 330
|
|
Cetuximab
|
Visite: 199
|
|
Ciclofosfamide
|
Visite: 179
|
|
Cisplatino
|
Visite: 193
|
|
La citarabina
|
Visite: 159
|
|
Cladribina
|
Visite: 188
|
|
Chlorambucil
|
Visite: 288
|
|
Chlormethinum
|
Visite: 291
|
|
Dacarbazina
|
Visite: 149
|
|
Dactinomicina
|
Visite: 198
|
|
Daunorubicina
|
Visite: 152
|
|
Docetaxel
|
Visite: 152
|
|
Doxorubicina
|
Visite: 316
|
|
Epirubucin
|
Visite: 143
|
|
Erlotinib
|
Visite: 150
|
|
Etoposide
|
Visite: 176
|
|
Exemestano
|
Visite: 202
|
|
Fluorouracile Topico Soluzione
|
Visite: 133
|
|
Fluorouracile
|
Visite: 205
|
|
Gemcitabina
|
Visite: 139
|
|
Idarubicina-Hcl
|
Visite: 172
|
|
Ifosfamide
|
Visite: 138
|
|
Melfalan
|
Visite: 134
|
|
Mercaptopurina
|
Visite: 177
|
|
Methotrexate
|
Visite: 230
|
|
Mitomicina
|
Visite: 231
|
|
Mitoxantrone
|
Visite: 144
|
|
Oxaliplatino
|
Visite: 124
|
|
Paclitaxel
|
Visite: 168
|
|
Pentostatina
|
Visite: 169
|
|
Procarbazina
|
Visite: 144
|
|
Rituximab
|
Visite: 190
|
|
Teniposide
|
Visite: 139
|
|
Tioguanina
|
Visite: 124
|
|
Tiotepa
|
Visite: 130
|
|
Trastuzumab
|
Visite: 174
|
|
Tretinoin Orale
|
Visite: 173
|
|
Vinblastina
|
Visite: 147
|
|
Vincristina
|
Visite: 139
|
|
Vinorelbine Tartrate
|
Visite: 158
|
|
Everolimus
|
Visite: 154
|
|
Imatinib Mesilato
|
Visite: 153
|
|
Nilotinib
|
Visite: 190
|
|
Dasatinib
|
Visite: 147
|
|
Pazopanib
|
Visite: 130
|
|
Ipilimumab
|
Visite: 131
|
|
Nivolumab
|
Visite: 173
|
|
Brentuximab Vedotin
|
Visite: 160
|